BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9591045)

  • 1. An enzyme-linked immunosorbent assay for the measurement of circulating antibodies to polymorphic epithelial mucin (MUC1).
    von Mensdorff-Pouilly S; Gourevitch MM; Kenemans P; Verstraeten AA; van Kamp GJ; Kok A; van Uffelen K; Snijdewint FG; Paul MA; Meijer S; Hilgers J
    Tumour Biol; 1998; 19(3):186-95. PubMed ID: 9591045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival in early breast cancer patients is favorably influenced by a natural humoral immune response to polymorphic epithelial mucin.
    von Mensdorff-Pouilly S; Verstraeten AA; Kenemans P; Snijdewint FG; Kok A; Van Kamp GJ; Paul MA; Van Diest PJ; Meijer S; Hilgers J
    J Clin Oncol; 2000 Feb; 18(3):574-83. PubMed ID: 10653872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of circulating anti-mucin 1 (MUC1) antibodies in breast tumor patients by indirect enzyme-linked immunosorbent assay using a recombinant MUC1 protein containing six tandem repeats and expressed in Escherichia coli.
    Tang Y; Wang L; Zhang P; Wei H; Gao R; Liu X; Yu Y; Wang L
    Clin Vaccine Immunol; 2010 Dec; 17(12):1903-8. PubMed ID: 20876819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular and humoral immune responses to MUC1 mucin and tandem-repeat peptides in ovarian cancer patients and controls.
    Snijdewint FG; von Mensdorff-Pouilly S; Karuntu-Wanamarta AH; Verstraeten AA; van Zanten-Przybysz I; Hummel P; Nijman HW; Kenemans P; Hilgers J
    Cancer Immunol Immunother; 1999 Apr; 48(1):47-55. PubMed ID: 10235488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies reactive with the protein core of MUC1 mucin are present in ovarian cancer patients and healthy women.
    Richards ER; Devine PL; Quin RJ; Fontenot JD; Ward BG; McGuckin MA
    Cancer Immunol Immunother; 1998 Jul; 46(5):245-52. PubMed ID: 9690452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral immune response induced by the protein core of MUC1 mucin in pregnant and healthy women.
    Croce MV; Isla-Larrain MT; Capafons A; Price MR; Segal-Eiras A
    Breast Cancer Res Treat; 2001 Sep; 69(1):1-11. PubMed ID: 11759823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue and serum MUC1 mucin detection in breast cancer patients.
    Croce MV; Isla-Larrain MT; Demichelis SO; Gori JR; Price MR; Segal-Eiras A
    Breast Cancer Res Treat; 2003 Oct; 81(3):195-207. PubMed ID: 14620915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer humoral immune response: involvement of Lewis y through the detection of circulating immune complexes and association with Mucin 1 (MUC1).
    Isla Larrain M; Demichelis S; Crespo M; Lacunza E; Barbera A; Cretón A; Terrier F; Segal-Eiras A; Croce MV
    J Exp Clin Cancer Res; 2009 Aug; 28(1):121. PubMed ID: 19715603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactivity of natural and induced human antibodies to MUC1 mucin with MUC1 peptides and n-acetylgalactosamine (GalNAc) peptides.
    von Mensdorff-Pouilly S; Petrakou E; Kenemans P; van Uffelen K; Verstraeten AA; Snijdewint FG; van Kamp GJ; Schol DJ; Reis CA; Price MR; Livingston PO; Hilgers J
    Int J Cancer; 2000 Jun; 86(5):702-12. PubMed ID: 10797294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of Salivary and Serum Auto-antibodies Against Tumor Biomarkers HER2 and MUC1 in Breast Cancer Screening.
    Laidi F; Bouziane A; Errachid A; Zaoui F
    Asian Pac J Cancer Prev; 2016; 17(1):335-9. PubMed ID: 26838233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a new MUC1 monoclonal antibody (VU-2-G7) directed to the glycosylated PDTR sequence of MUC1.
    Ryuko K; Schol DJ; Snijdewint FG; von Mensdorff-Pouilly S; Poort-Keesom RJ; Karuntu-Wanamarta YA; Verstraeten RA; Miyazaki K; Kenemans P; Hilgers J
    Tumour Biol; 2000; 21(4):197-210. PubMed ID: 10867613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral immune responses to MUC1 in women with a BRCA1 or BRCA2 mutation.
    Hermsen BB; Verheijen RH; Menko FH; Gille JJ; van Uffelen K; Blankenstein MA; Meijer S; van Diest PJ; Kenemans P; von Mensdorff-Pouilly S
    Eur J Cancer; 2007 Jul; 43(10):1556-63. PubMed ID: 17532207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral immune response to polymorphic epithelial mucin (MUC-1) in patients with benign and malignant breast tumours.
    von Mensdorff-Pouilly S; Gourevitch MM; Kenemans P; Verstraeten AA; Litvinov SV; van Kamp GJ; Meijer S; Vermorken J; Hilgers J
    Eur J Cancer; 1996 Jul; 32A(8):1325-31. PubMed ID: 8869094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral immune response against tumoral mucin 1 (MUC1) in breast cancer patients.
    Isla Larrain MT; Colussi AG; Demichelis SO; Barbera A; Cretón A; Segal-Eiras A; Croce MV
    Int J Biol Markers; 2013 Sep; 28(3):318-25. PubMed ID: 23828406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-dependent cell-mediated cytotoxicity can be induced by MUC1 peptide vaccination of breast cancer patients.
    Snijdewint FG; von Mensdorff-Pouilly S; Karuntu-Wanamarta AH; Verstraeten AA; Livingston PO; Hilgers J; Kenemans P
    Int J Cancer; 2001 Jul; 93(1):97-106. PubMed ID: 11391628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epitope mapping of anti-MUC1 mucin protein core monoclonal antibodies.
    Petrakou E; Murray A; Price MR
    Tumour Biol; 1998; 19 Suppl 1():21-9. PubMed ID: 9422085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble MUC1 and serum MUC1-specific antibodies are potential prognostic biomarkers for platinum-resistant ovarian cancer.
    Budiu RA; Mantia-Smaldone G; Elishaev E; Chu T; Thaller J; McCabe K; Lenzner D; Edwards RP; Vlad AM
    Cancer Immunol Immunother; 2011 Jul; 60(7):975-84. PubMed ID: 21461842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphic epithelial mucin (MUC-1)-containing circulating immune complexes in carcinoma patients.
    Gourevitch MM; von Mensdorff-Pouilly S; Litvinov SV; Kenemans P; van Kamp GJ; Verstraeten AA; Hilgers J
    Br J Cancer; 1995 Oct; 72(4):934-8. PubMed ID: 7547243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis.
    Blixt O; Bueti D; Burford B; Allen D; Julien S; Hollingsworth M; Gammerman A; Fentiman I; Taylor-Papadimitriou J; Burchell JM
    Breast Cancer Res; 2011 Mar; 13(2):R25. PubMed ID: 21385452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of circulating mammary mucin (Muc1) and MUC1 immune complexes (Muc1-CIC) in healthy women.
    Croce MV; Isla-Larrain MT; Price MR; Segal-Eiras A
    Int J Biol Markers; 2001; 16(2):112-20. PubMed ID: 11471893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.